I would like to start by welcoming our authors and experts to our form discussion re: this months NEJM Perspective Piece, “Mitochondrial Replacement Techniques- Implications for the Clinical Community.” Over the next several days I hope help stimulate a debate regarding this technologies role, implication, application, and cost.
We will start the discussion today by addressing the diseases this technology aims to treat. About one in 200 people is born with a pathogenic mtDNA mutation and one in 5,000-10,000 people develop a symptomatic mitochondrial disease. However, the incidence rates may be higher considering the difficulty of accurate diagnosis and the diversity of clinical presentations.
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this challenge
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.